Fischer Medical Ventures Ltd

Fischer Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fischer Medical Ventures Ltd

₹ 49.5 2.40%
02 Dec 1:39 p.m.
fischermv.com BSE: 524743 NSE: FISCHER
About

Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]

Key Points

Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals

Website BSE NSE
  • Market Cap ₹ 3,212 Cr.
  • Current Price ₹ 49.5
  • High / Low ₹ 125 / 40.8
  • Stock P/E 160
  • Book Value ₹ 5.55
  • Dividend Yield 0.01 %
  • ROCE 1.08 %
  • ROE 0.70 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company's working capital requirements have reduced from 287 days to 39.9 days

Cons

  • Stock is trading at 8.60 times its book value
  • Earnings include an other income of Rs.10.2 Cr.
  • Company has high debtors of 251 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
0 21 10 40 12 49 23 86
0 18 10 39 11 47 19 70
Operating Profit 0 3 -0 0 0 2 4 16
OPM % 12% -2% 1% 3% 5% 18% 19%
0 0 1 0 0 0 7 2
Interest 0 0 0 0 0 0 1 1
Depreciation 0 0 0 0 1 1 1 1
Profit before tax 0 3 0 0 0 2 10 17
Tax % 6% 271% -38% 350% 28% 51% 19%
0 3 -0 0 -0 1 5 14
EPS in Rs 0.00 0.05 -0.00 0.01 -0.01 0.02 0.08 0.21
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 TTM
0 21 111 171
0 19 108 147
Operating Profit 0 2 3 23
OPM % 11% 9% 3% 14%
0 0 1 10
Interest 0 0 0 2
Depreciation 0 0 2 2
Profit before tax 0 2 2 29
Tax % 13% 45%
-0 2 1 20
EPS in Rs -0.24 0.03 0.02 0.30
Dividend Payout % 0% 0% 22%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 428%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 7%
Stock Price CAGR
10 Years: 66%
5 Years: 71%
3 Years: 89%
1 Year: -23%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.17 54 64 65
Reserves -0 28 274 295
1 2 85 30
0 4 34 77
Total Liabilities 0 86 457 468
0 15 24 31
CWIP 0 0 1 2
Investments 0 1 11 121
0 70 421 313
Total Assets 0 86 457 468

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
-7 -87
-29 -125
37 315
Net Cash Flow 1 103

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025
Debtor Days 345 398 251
Inventory Days 99 36
Days Payable 48 82
Cash Conversion Cycle 345 449 205
Working Capital Days 324 498 40
ROCE % 5% 1%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 74.91% 74.91% 74.91% 62.82% 61.80% 61.80%
0.00% 0.00% 0.00% 0.00% 0.00% 5.07% 5.07% 5.07% 5.07% 5.23% 5.55% 5.57%
0.00% 0.00% 0.00% 0.00% 0.00% 1.68% 1.68% 1.68% 1.68% 1.44% 1.42% 1.42%
100.00% 100.00% 99.99% 100.00% 99.99% 93.24% 18.33% 18.33% 18.32% 30.51% 31.23% 31.22%
No. of Shareholders 9,0649,0609,1009,1049,0388,9769,2859,5029,68810,18010,05813,054

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls